Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression

作者: J. M. Drake , N. A. Graham , T. Stoyanova , A. Sedghi , A. S. Goldstein

DOI: 10.1073/PNAS.1120985109

关键词: Cyclin-dependent kinase 9Protein tyrosine phosphataseROR1Platelet-derived growth factor receptorReceptor tyrosine kinaseBruton's tyrosine kinaseProto-oncogene tyrosine-protein kinase SrcBiologyCancer researchTyrosine phosphorylation

摘要: Dominant mutations or DNA amplification of tyrosine kinases are rare among the oncogenic alterations implicated in prostate cancer. We demonstrate that castration-resistant prostate …

参考文章(60)
Rodrigo Dienstmann, Pablo Martinez, Enriqueta Felip, Personalizing Therapy with Targeted Agents in Non-Small Cell Lung Cancer Oncotarget. ,vol. 2, pp. 165- 177 ,(2011) , 10.18632/ONCOTARGET.245
Michael M. Lieber, David G. Bostwick, Junqi Qian, Robert B. Jenkins, Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Research. ,vol. 57, pp. 524- 531 ,(1997)
Noah Craft, Yuriy Shostak, Michael Carey, Charles L. Sawyers, A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nature Medicine. ,vol. 5, pp. 280- 285 ,(1999) , 10.1038/6495
Nicole Dodge Zantek, Michael S. Kinch, Daniel P. Zelinski, Jane C. Stewart, Armando R. Irizarry, EphA2 overexpression causes tumorigenesis of mammary epithelial cells Cancer Research. ,vol. 61, pp. 2301- 2306 ,(2001)
Tarek A. Bismar, Maisa Yoshimoto, Robin T. Vollmer, Qiuli Duan, Matthew Firszt, Jacques Corcos, Jeremy A. Squire, PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer BJUI. ,vol. 107, pp. 477- 485 ,(2011) , 10.1111/J.1464-410X.2010.09470.X
J. Chad Brenner, Arul M. Chinnaiyan, Translocations in epithelial cancers. Biochimica et Biophysica Acta. ,vol. 1796, pp. 201- 215 ,(2009) , 10.1016/J.BBCAN.2009.04.005
Giuseppe Curigliano, Giuseppe Pelosi, Tommaso De Pas, Giuseppe Renne, Ottavio De Cobelli, Michela Manzotti, Gianluca Spitaleri, Filippo de Braud, Absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib The Prostate. ,vol. 67, pp. 603- 604 ,(2007) , 10.1002/PROS.20530
Magali Olivier, Philippe Taniere, Somatic mutations in cancer prognosis and prediction: lessons from TP53 and EGFR genes Current Opinion in Oncology. ,vol. 23, pp. 88- 92 ,(2011) , 10.1097/CCO.0B013E3283412DFA
Zhengyan Kan, Bijay S. Jaiswal, Jeremy Stinson, Vasantharajan Janakiraman, Deepali Bhatt, Howard M. Stern, Peng Yue, Peter M. Haverty, Richard Bourgon, Jianbiao Zheng, Martin Moorhead, Subhra Chaudhuri, Lynn P. Tomsho, Brock A. Peters, Kanan Pujara, Shaun Cordes, David P. Davis, Victoria E. H. Carlton, Wenlin Yuan, Li Li, Weiru Wang, Charles Eigenbrot, Joshua S. Kaminker, David A. Eberhard, Paul Waring, Stephan C. Schuster, Zora Modrusan, Zemin Zhang, David Stokoe, Frederic J. de Sauvage, Malek Faham, Somasekar Seshagiri, Diverse somatic mutation patterns and pathway alterations in human cancers Nature. ,vol. 466, pp. 869- 873 ,(2010) , 10.1038/NATURE09208
Madhu Macrae, Richard M. Neve, Pablo Rodriguez-Viciana, Christopher Haqq, Jennifer Yeh, Chira Chen, Joe W. Gray, Frank McCormick, A conditional feedback loop regulates Ras activity through EphA2 Cancer Cell. ,vol. 8, pp. 111- 118 ,(2005) , 10.1016/J.CCR.2005.07.005